A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/495 (2006.01) A61P 11/00 (2006.01)
Patent
CA 2441096
This invention relates to the use of nicotine receptor agonists analogues or derivatives thereof for treating pulmonary inflammatory diseases, including asthma, interstitial pulmonary fibrosis (IPF), sarcoidosis, hypersensitivity pneumonitis (HP), chronic HP and bronchiolitis obliterans with organizing pneumonitis (BOOP). Such agonists are expected to have fewer side effects than other anti-inflammatory drugs, such as steroids. Moreover, these agonists can be used alone or in combination with other anti- inflammatory drugs to alleviate pulmonary diseases.
La présente invention concerne l'utilisation d'agonistes de récepteurs nicotiniques pour le traitement d'affections inflammatoires, y-compris des affections pulmonaires. De tels agonistes s'avèrent entraîner moins d'effets secondaires que d'autres anti-inflammatoires tels que les stéroïdes. En outre, ces agonistes peuvent s'utiliser seuls ou en association avec d'autres anti-inflammatoires pour soulager des affections pulmonaires.
Blanchet Marie-Renee
Cormier Yvon
Israel-Assayag Evelyne
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Universite Laval
LandOfFree
Nicotinic receptor agonists for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nicotinic receptor agonists for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nicotinic receptor agonists for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1943141